# Amgen Inc. (AMGN) — Q1-2013 Earnings Results

**Report date:** 2013-04-23 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2013

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.58%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.96 | N/A | +12.26% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized the importance of their ongoing research and development efforts.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They acknowledged ongoing challenges in the market but expressed confidence in their pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a solid EPS beat, indicating better-than-expected profitability. However, the stock's slight decline of 0.58% suggests that investors may have been looking for more comprehensive guidance or revenue figures. The lack of revenue data and guidance could have contributed to the stock's downward movement, despite the positive EPS surprise.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q1-2013_